bild
SCHWEIZ SPITAL CHUV DOWN-SYNDROM
EMBARGO UNTIL 1. SEPTEMBER 2022 AT 20 PM CET - Switzerland's professor Nelly Pitteloud, Head of the Department of Endocrinology, Diabetology and Metabolism applies an injection box to a patient with down syndrome during a study of GnRH replacement rescues cognition in Down Syndrome at the University Hospital (CHUV), in Lausanne, Switzerland, Monday, August 22, 2022. The Institut at national de la sante et de la recherche medicale (Inserm, Lille), and the Centre hospitalier universitaire vaudois (CHUV, Lausanne) have collaborated to test the efficacy of a therapy based on the injection of the hormone GnRH to improve the cognitive functions of a small group of patients with Down syndrome. (KEYSTONE/Laurent Gillieron)
Instruktionen
EMBARGO UNTIL 1. SEPTEMBER 2022 AT 20 PM CET
Lizenz
Rights Managed
Erstellungsdatum
20220901
Ort
LAUSANNE SCHWEIZ
Credit
KEYSTONE
Source
KEYSTONE
Byline
LAURENT GILLIERON
Grösse
7883 x 5255 px
Dateityp
JPEG